USFDA Warns Aurobindo’s Eugia Pharma with a Warning Letter
MM Desk
19 August, 2024
Eugia Pharma Specialities, a fully owned subsidiary of Aurobindo Pharma, has recently received a warning
Eugia Pharma Specialities, a fully owned subsidiary of Aurobindo Pharma, has recently received a warning